Toll6, one of the receptors of the Toll pathway, is enriched in the tumor and governs the trajectory of invasive RasV12; scrib−/− cells toward specific organs (aka organotropism), through its binding to the ligand Spz. This evidence concerns the gene TLR4 and neoplasm.